Sprout Health vs MadeMed
Two GLP-1 desks, one scoreboard. We put Sprout Health and MadeMed head-to-head on the published Brief Score — the same six factors, scored the same way.
The verdict
Too close to call on the Brief Score.
Sprout Health and MadeMed are level at 86/100. The scores won't separate them, so the pick comes down to fit: Sprout Health for patients who want a low compounded entry price but the option of brand-name wegovy or zepbound on the same account, with minimal onboarding. MadeMed for readers who want to know the exact cost of a titrated dose before starting, and who intend to climb to a full dose.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Sprout Health | MadeMed | |
|---|---|---|
| Brief Score | 86/100 (B) | 86/100 (B) |
| Semaglutide | $149/mo | $239/mo injectable · $219/mo sublingual (quarterly) |
| Tirzepatide | $199/mo | $399/mo injectable · $299/mo sublingual (quarterly) |
| Coverage | Not disclosed | 40 states |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Injection only | Yes |
| On the tracker | Stableprice stable | Stableprice stable |
Sprout Health: Compounded $149 semaglutide / $199 tirzepatide held flat this cycle, with a brand-name Wegovy/Zepbound path available on the same account.
MadeMed: Publishes one price per route that holds at every dose — the cleanest dose-to-price mapping we track.
● Not sold on either?
CoreAge Rx tops the whole board at 94/100.
The steadiest desk on the board: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.